Literature DB >> 16731027

Sequential observation of movement disorders and brain images in the case of central pontine myelinolysis and extrapontine myelinolysis.

Jung Im Seok1, Jinyoung Youn, Eun Joo Chung, Won Yong Lee.   

Abstract

Central pontine myelinolysis (CPM) and extrapontine myelinolysis (EPM) are well recognized syndromes related to rapid correction of hyponatremia and have been reported to show a variety of movement disorders. However, sequential observation of movement disorders as well as brain images has seldom been reported. We report a case of CPM and EPM presenting with various sequential changes in movement disorders including delayed choreic movement over 11 months; we present sequential brain magnetic resonance images showing increased T1 and decreased fat-suppression T1 signal intensity. We suggest that delayed low signal intensity, in the fat-suppression T1-weighted images, is a result of the destruction of myelin and by products. Damage to the myelin may cause various movement disorders in a delayed manner.

Entities:  

Mesh:

Year:  2006        PMID: 16731027     DOI: 10.1016/j.parkreldis.2006.02.002

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  3 in total

1.  Metabolic disorders with clinical and radiologic features of sporadic Creutzfeldt-Jakob disease.

Authors:  Michael H Rosenbloom; M Carmela Tartaglia; Sven A Forner; Katherine K Wong; Amy Kuo; David Y Johnson; Valerie Colacurcio; Bret D Andrews; Bruce L Miller; Stephen J DeArmond; Michael D Geschwind
Journal:  Neurol Clin Pract       Date:  2015-04

2.  Central pontine and extrapontine myelinolysis associated with acute hepatic dysfunction.

Authors:  Ying Chang; Dong-Hong An; Ying Xing; Xin Qi
Journal:  Neurol Sci       Date:  2011-11-13       Impact factor: 3.307

Review 3.  Extrapontine myelinolysis associated with pituitrin: case report and literature review.

Authors:  Liying Zhuang; Ziqi Xu; Yaguo Li; Benyan Luo
Journal:  BMC Neurol       Date:  2014-10-09       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.